FORWARD FEATURES CALENDAR

Deals

Blue Owl backs $4bn PCI Pharma deal

Blue Owl Capital is spearheading a private credit deal worth approximately $4bn for PCI Pharma Services, which, if finalised, would rank among the largest direct lending agreements of the year, according to a report by Bloomberg citing sources familiar with the matter.

Bain matches CC Capital’s Insignia Financial bid

Shares of Australia’s Insignia Financial surged to a three-year high on Monday as the bidding war intensified, with Bain Capital increasing its offer to AUD 2.87bn ($1.76bn), aligning with the rival bid from CC Capital, according to a report by Reuters.

EG Group eyes $13bn New York IPO

EG Group, a petrol station company supported by private equity firm TDR Capital, is preparing for an initial public offering in New York as early as this year that could value the business at approximately $13bn, according to a report by the Financial Times.

Antares, Blue Owl, and KKR to take on BlackRock’s Alacrity

Direct lenders, including Antares Capital, Blue Owl Capital, and KKR, are preparing to assume control of insurance claims manager Alacrity Solutions, marking the latest restructuring within the private credit market, according to a Bloomberg report citing sources familiar with the situation.

Warburg Pincus mulls $5bn-plus ModMed sale

Warburg Pincus is exploring strategic options for its portfolio company Modernizing Medicine, which could include a sale in a deal valued at over $5bn, including debt, according to a report by Reuters citing unnamed sources familiar with the matter.

Events

12 November, 2026 – 5:00 pm

Directory Listings